FirstHealth of the Carolinas Clinical Trials group is partnering with Wake Forest Medical School to further a research study on the development and progression of asbestos diseases, such as mesothelioma and asbestosis.
Dr. Jill Ohar of Wake Forest University has spent more than 20 years researching asbestos diseases. The current study examines both environmental factors and genetic markers of those with a mesothelioma diagnosis. The focus is to attempt to identify how often environmental pollutants affect the body, as well as genetic factors that perhaps make some families to susceptible to mesothelioma and other forms of asbestos cancer.
You may request more information about the clinical trial by contacting FirstHealth Clinical Trials at 910-715-2200. Or review our web site for more information about other mesothelioma clinical trials.
